Diaceutics Balance Sheet Health
Financial Health criteria checks 6/6
Diaceutics has a total shareholder equity of £41.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £46.1M and £5.1M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£17.88m |
Equity | UK£41.06m |
Total liabilities | UK£5.06m |
Total assets | UK£46.12m |
Recent financial health updates
No updates
Recent updates
Diaceutics PLC's (LON:DXRX) Subdued P/S Might Signal An Opportunity
Jan 31Industry Analysts Just Made A Notable Upgrade To Their Diaceutics PLC (LON:DXRX) Revenue Forecasts
Jan 28Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)
Jul 24Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?
Feb 04Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 31Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?
Nov 27Financial Position Analysis
Short Term Liabilities: DXRX's short term assets (£28.0M) exceed its short term liabilities (£3.5M).
Long Term Liabilities: DXRX's short term assets (£28.0M) exceed its long term liabilities (£1.6M).
Debt to Equity History and Analysis
Debt Level: DXRX is debt free.
Reducing Debt: DXRX has no debt compared to 5 years ago when its debt to equity ratio was 129.3%.
Debt Coverage: DXRX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DXRX has no debt, therefore coverage of interest payments is not a concern.